Equine CA199 antibody and antigen (recombinant protein)

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-EQU-CA199-Ag01	Recombinant Equine CA199 protein	3090
GMP-EQU-CA199-Ab01	Anti-Equine CA199 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-CA199-Ab02	Anti-Equine CA199 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-CA199-Ab03	Anti-Equine CA199 mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-CA199-Ab04	Anti-Equine CA199 mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-EQU-CA199-Ag01
Product Name	Recombinant Equine CA199 protein
Target/Biomarker	Equine Carbohydrate antigen 19-9 (CA199)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Equine Carbohydrate antigen 19-9 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA199 level test of animal Equine/Horse with pancreatic and biliary tract tumors.
Tag	His
Products description	Recombinant Equine CA199 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-CA199-Ab01, GMP-EQU-CA199-Ab02, GMP-EQU-CA199-Ab03, GMP-EQU-CA199-Ab04
Product Name	Anti-Equine CA199 mouse monoclonal antibody (mAb)
Target/Biomarker	Equine Carbohydrate antigen 19-9 (CA199)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Anti-Equine Carbohydrate antigen 19-9 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA199 level test of animal Equine/Horse with pancreatic and biliary tract tumors.
Tag	mFc
Products description	Anti-Equine CA199 mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Cancer Antigen 199 (CA199) is a glycoprotein biomarker with vital implications in equine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in horses, including those affecting the gastrointestinal tract and pancreas. Structurally, CA199 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules. In the context of equine health, CA199 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the gastrointestinal and pancreatic regions can be insidious, often presenting with subtle or nonspecific clinical signs. CA199 blood tests offer a non-invasive and highly sensitive means of identifying these malignancies, enabling prompt intervention and potentially improving treatment outcomes. CA199 levels in a horse's bloodstream become elevated when cancer cells, particularly those found in the gastrointestinal and pancreatic cancers, produce and release this glycoprotein. As a result, CA199 serves as a biomarker that can be readily detected and quantified through blood tests.

About GDU